Randall Moreadith
President and CEO @Serina Therapeutics, Inc
Signup · Get unlimited contacts
WORK HISTORY
President and CEO @Serina Therapeutics, Inc
Serina Therapeutics, Inc. has developed a proprietary drug delivery polymer technology based upon the polymer poly(2-oxazoline), or POZ™. We are developing a pipeline of proprietary and partnered programs applying this platform to Parkinson\'s disease, cannabinoids, cancer, and pain. Most recently we have applied POZ technology to developing a nonimmunogenic lipid nanoparticle (LNP) for use across multiple indications - from SARS-CoV-2 to influenza to gene therapy and cancer immunotherapy. Please visit to take a look at what we\'re accomplishing.
EDUCATION
Harvard University
Howard Hughes Fellow, Molecular Genetics
Duke University School of Medicine
MD, Internal Medicine - Cardiology
The Johns Hopkins University School of Medicine
Doctor of Philosophy - PhD, Cellular and Molecular Biology
SKILLS
ABOUT RANDALL MOREADITH
Experienced C-suite executive with a successful history of drug development for over 25…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.